A full registration dossier covers what the product is, how toxic it is, what it does in the environment, whether it works and what residues it leaves on food. The exact list depends on your country, the crop and whether the active is new or generic.
For a generic product, much of the hazard data for the active may already be on file with the regulator. You then usually need data showing your source is equivalent to the reference, plus product-specific data for your formulation.
The main data blocks
- Identity and chemistry data gives the active's name, structure, CAS number, manufacturing process, specification and validated analytical methods.
- Batch data is a five-batch analysis showing active content and impurities in recent production batches.
- Physical and chemical data covers the technical and the formulation, including storage stability.
- Toxicology covers acute studies such as oral, dermal and inhalation toxicity, skin and eye irritation and sensitisation, plus longer studies for a new active.
- Ecotoxicology covers effects on birds, fish, aquatic invertebrates, algae, bees and soil organisms.
- Environmental fate data shows how the active breaks down in soil and water and whether it moves to groundwater.
- Efficacy trials show the product controls the target pest at the label dose without harming the crop.
- Residue trials measure residue levels in treated crops, to support maximum residue limits.
Which parts come from the supplier
The manufacturer usually holds the chemistry and batch data, because only it knows its process. It may also own acute toxicology and physical property studies for its technical and formulations. Efficacy and residue trials are often run in your country, because regulators want local conditions.
Many regulators require studies to be done under Good Laboratory Practice. See what GLP is and how to check a lab in India. The batch study is explained in what a five-batch analysis is.
The supplier should also provide validated analytical methods for the active and its relevant impurities. Your regulator's lab or a contract lab will use these to check samples, so methods that are vague or unvalidated cause delays.
The process description and impurity profile are confidential. Suppliers normally send them directly to the regulator, or release them under a confidentiality agreement.
Access to data you do not own
Some data on an active is protected for a period and owned by the original applicant. You may need a letter of access from the owner, or must generate your own studies. Rules on data protection and sharing differ by country, so check them with your regulator or a regulatory consultant early.
Plan the budget and timeline around these gaps. Buying or generating missing studies can take longer than any other part of the project. A source that already holds most of the data can save years, even if its quote is not the lowest.
Next step
We check what data a manufacturer actually holds before you build a dossier around it. Book a free sourcing review to map your data needs to the right plant.